These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. INR variability and outcomes in patients with mechanical heart valve prosthesis. Labaf A; Själander A; Stagmo M; Svensson PJ Thromb Res; 2015 Dec; 136(6):1211-5. PubMed ID: 26558830 [TBL] [Abstract][Full Text] [Related]
3. Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis. Grzymala-Lubanski B; Svensson PJ; Renlund H; Jeppsson A; Själander A Heart; 2017 Feb; 103(3):198-203. PubMed ID: 27590664 [TBL] [Abstract][Full Text] [Related]
4. Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA. Wieloch M; Själander A; Frykman V; Rosenqvist M; Eriksson N; Svensson PJ Eur Heart J; 2011 Sep; 32(18):2282-9. PubMed ID: 21616951 [TBL] [Abstract][Full Text] [Related]
5. Thromboembolism, major bleeding and mortality in patients with mechanical heart valves- a population-based cohort study. Labaf A; Grzymala-Lubanski B; Stagmo M; Lövdahl S; Wieloch M; Själander A; Svensson PJ Thromb Res; 2014 Aug; 134(2):354-9. PubMed ID: 24985036 [TBL] [Abstract][Full Text] [Related]
7. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED; J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973 [TBL] [Abstract][Full Text] [Related]
8. Mitral valve repair and bioprosthetic replacement without postoperative anticoagulation does not increase the risk of stroke or mortality. Schwann TA; Engoren M; Bonnell M; Clancy C; Khouri S; Kabour A; Jamil T; Habib RH Eur J Cardiothorac Surg; 2013 Jul; 44(1):24-31. PubMed ID: 23293318 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Wallentin L; Lopes RD; Hanna M; Thomas L; Hellkamp A; Nepal S; Hylek EM; Al-Khatib SM; Alexander JH; Alings M; Amerena J; Ansell J; Aylward P; Bartunek J; Commerford P; De Caterina R; Erol C; Harjola VP; Held C; Horowitz JD; Huber K; Husted S; Keltai M; Lanas F; Lisheng L; McMurray JJ; Oh BH; Rosenqvist M; Ruzyllo W; Steg PG; Vinereanu D; Xavier D; Granger CB; Circulation; 2013 Jun; 127(22):2166-76. PubMed ID: 23640971 [TBL] [Abstract][Full Text] [Related]
10. Twenty years' single-center experience with mechanical heart valves: a critical review of anticoagulation policy. Van Nooten GJ; Caes F; François K; Van Bellleghem Y; Bové T; Vandenplas G; Taeymans Y J Heart Valve Dis; 2012 Jan; 21(1):88-98. PubMed ID: 22474748 [TBL] [Abstract][Full Text] [Related]
11. Warfarin treatment quality is consistently high in both anticoagulation clinics and primary care setting in Sweden. Björck F; Sandén P; Renlund H; Svensson PJ; Själander A Thromb Res; 2015 Aug; 136(2):216-20. PubMed ID: 25935649 [TBL] [Abstract][Full Text] [Related]
12. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study. Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of warfarin in paediatric patients with prosthetic cardiac valves: a retrospective audit. Wong CS; Batchelor K; Bua J; Newall F Thromb Res; 2011 Oct; 128(4):331-4. PubMed ID: 21620442 [TBL] [Abstract][Full Text] [Related]
14. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. Turpie AG; Gent M; Laupacis A; Latour Y; Gunstensen J; Basile F; Klimek M; Hirsh J N Engl J Med; 1993 Aug; 329(8):524-9. PubMed ID: 8336751 [TBL] [Abstract][Full Text] [Related]
15. Adequate intensity of warfarin therapy for Korean patients with mechanical cardiac valves. Yoon IK; Lee KE; Lee JK; Chang BC; Gwak HS J Heart Valve Dis; 2013 Jan; 22(1):102-9. PubMed ID: 23610997 [TBL] [Abstract][Full Text] [Related]
16. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Douketis JD; Johnson JA; Turpie AG Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166 [TBL] [Abstract][Full Text] [Related]
17. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin. McLintock C; McCowan LM; North RA BJOG; 2009 Nov; 116(12):1585-92. PubMed ID: 19681850 [TBL] [Abstract][Full Text] [Related]
18. INR Control of Patients with Mechanical Heart Valve on Long-Term Warfarin Therapy. Tan CSY; Fong AYY; Jong YH; Ong TK Glob Heart; 2018 Dec; 13(4):241-244. PubMed ID: 30213574 [TBL] [Abstract][Full Text] [Related]
19. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP). Pengo V; Palareti G; Cucchini U; Molinatti M; Del Bono R; Baudo F; Ghirarduzzi A; Pegoraro C; Iliceto S; Clin Appl Thromb Hemost; 2007 Jul; 13(3):241-8. PubMed ID: 17636186 [TBL] [Abstract][Full Text] [Related]
20. Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community setting. Han SY; Palmeri ST; Broderick SH; Hasselblad V; Rendall D; Stevens S; Tenaglia A; Velazquez E; Whellan D; Wagner G; Heitner JF J Electrocardiol; 2013; 46(1):45-50. PubMed ID: 23063241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]